U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07237113) titled 'Muscle Recovery After Omega-3 Supplementation' on Nov. 14.
Brief Summary: In recent decades, omega-3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been proposed as potential therapeutic agents for minimizing muscle damage induced by eccentric exercise, especially when supplementation is long-term (> 6 weeks) and at high doses (> 1 g/d). However, no study has analyzed whether these effects are mediated by an increase in oxylipins (metabolites derived from EPA and DHA), which play an essential role in the muscle regeneration process. The objective of the present study is to determine the effect of eight weeks of high...